Principal Investigator: Professor Rosalind Eeles
Professor Rosalind (Ros) Eeles has been instrumental in ensuring new discoveries in cancer genetics immediately benefit patients, particularly in her specialty areas of BRCA-mutation carriers and prostate cancer.
Professor Eeles is a clinician as well as a scientist, running both a laboratory at The Institute of Cancer Research, London and a Cancer Genetics and Uro-Oncology Clinic at The Royal Marsden NHS Foundation Trust. She trained at the University of Cambridge and St Thomas’ Hospital Medical School.
She then underwent higher medical training and is a Fellow of the Royal College of Physicians of London. She trained in Clinical Oncology at The Royal Marsden. She is a Fellow of the Academy of Medical Sciences in London, and is a Fellow of the Royal College of Radiologists (Clinical Oncology Faculty), UK.
Her research training was in genetic predisposition to cancer at the ICR and she has a PhD in Cancer Genetics from the University of London. She spent a year in the US where she worked in research in cancer genetics and had oncology clinical experience.
She now leads a programme of research at the ICR in genetic predisposition to prostate cancer and management of individuals with BRCA mutations. She is an author on around 400 papers and has edited a major textbook on genetic predisposition to cancer.
Professor Eeles is accredited in clinical oncology with a sub-specialism in cancer genetics – cancer risk assessment, genetic testing for predisposition to cancer, targeted screening advice based on cancer genetic risk assessment and the application of cancer genetics to cancer care.
She sits on several genetics advisory committees both national and international. Her clinical oncology practice is in urological oncology.
PA and Assistant to Prof R Eeles
Lorna Barkazi and Alison Thwaites